167 related articles for article (PubMed ID: 9249242)
1. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study.
Waldeck K; Lindberg BF; Persson K; Andersson KE
Br J Pharmacol; 1997 Jul; 121(6):1081-6. PubMed ID: 9249242
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle.
Lindberg BF; Nilsson LG; Hedlund H; Stahl M; Andersson KE
Am J Physiol; 1994 Jun; 266(6 Pt 2):R1861-7. PubMed ID: 8024040
[TBL] [Abstract][Full Text] [Related]
3. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system.
Nishimura H; Buikema H; Baltatu O; Ganten D; Urata H
Am J Physiol; 1998 Oct; 275(4):H1307-12. PubMed ID: 9746480
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
[TBL] [Abstract][Full Text] [Related]
5. Alternative pathways of angiotensin II production in the human saphenous vein.
Borland JA; Chester AH; Morrison KA; Yacoub MH
Br J Pharmacol; 1998 Oct; 125(3):423-8. PubMed ID: 9806322
[TBL] [Abstract][Full Text] [Related]
6. Modulation of angiotensin-converting enzyme by nitric oxide.
Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C
Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545
[TBL] [Abstract][Full Text] [Related]
7. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
8. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
Liao Y; Husain A
Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
[TBL] [Abstract][Full Text] [Related]
9. Dual pathway for angiotensin II formation in human internal mammary arteries.
Voors AA; Pinto YM; Buikema H; Urata H; Oosterga M; Rooks G; Grandjean JG; Ganten D; van Gilst WH
Br J Pharmacol; 1998 Nov; 125(5):1028-32. PubMed ID: 9846641
[TBL] [Abstract][Full Text] [Related]
10. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats.
Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M
Jpn J Pharmacol; 2000 Dec; 84(4):449-54. PubMed ID: 11202618
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
[TBL] [Abstract][Full Text] [Related]
12. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum.
Iwamoto Y; Song K; Takai S; Yamada M; Jin D; Sakaguchi M; Ueda H; Katsuoka Y; Miyazaki M
J Pharmacol Exp Ther; 2001 Jul; 298(1):43-8. PubMed ID: 11408523
[TBL] [Abstract][Full Text] [Related]
13. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
14. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.
Katugampola SD; Davenport AP
Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656
[TBL] [Abstract][Full Text] [Related]
15. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
16. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
Hu WY; Fukuda N; Ikeda Y; Suzuki R; Tahira Y; Takagi H; Matsumoto K; Kanmatsuse K; Mugishima H
J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821
[TBL] [Abstract][Full Text] [Related]
17. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and vascular actions of decapeptide angiotensin analogs.
Baker KM; Khosla MC
J Pharmacol Exp Ther; 1986 Dec; 239(3):790-6. PubMed ID: 3025418
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
He S; Gaça MD; McEuen AR; Walls AF
J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
